Hematology/Oncology

Top Story

Pembrolizumab plus chemotherapy extends PFS in breast cancer subset

May 29, 2020

Read the Perspective from Amy Tiersten, MD

Meeting News

Adjuvant dabrafenib-trametinib provides ‘real chance to cure’ BRAF-mutant melanoma

May 29, 2020
Adjuvant dabrafenib and trametinib provided long-term benefit for patients with resected stage III BRAF V600-mutant melanoma, according to an analysis of the COMBI-AD…
Meeting NewsPerspective

Pembrolizumab extends PFS in relapsed or refractory classical Hodgkin lymphoma

May 29, 2020
Pembrolizumab extended PFS compared with brentuximab vedotin for patients with relapsed or refractory classic Hodgkin lymphoma, according to study results presented…
Meeting News

Mobility program benefits hospitalized patients with cancer

May 29, 2020
A mobility program significantly decreased health care utilization among hospitalized patients with cancer, according to study results presented during the ASCO20…
Meeting NewsPerspective

Pembrolizumab plus axitinib prolongs survival in advanced renal cell carcinoma

May 29, 2020
First-line pembrolizumab plus axitinib extended survival among patients with advanced renal cell carcinoma, according to updated results of the randomized phase 3…
More Headlines »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next